Bio Rad Laboratories Inc

BIO

301.500USD

+1.960+0.65%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

Bio Rad Laboratories Inc's Score

Industry at a Glance

Industry Ranking

26 / 205

Overall Ranking

108 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Bio Rad Laboratories Inc Highlights

StrengthsRisks

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Fairly Valued

The company’s latest PE is -12.56, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 20.58M shares, decreasing 0.02% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 151.00 shares of this stock.

Analyst Rating

Based on 6 analysts

Buy

Current Rating

355.000

Target Price

+18.52%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Bio Rad Laboratories Inc is 7.72, ranking 71 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 653.00M, representing a year-over-year increase of 0.50%, while its net profit experienced a year-over-year increase of 152.34%.

Score

Industry at a Glance

Previous score

7.72

Change

0



Financials

7.97

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.30

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.11

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.95

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.28

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Bio Rad Laboratories Inc is 8.52, ranking 18 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -12.56, which is -344.14% below the recent high of 30.65 and -456.27% above the recent low of -69.84.

Score

Industry at a Glance

Previous score

8.52

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 26/205

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Bio Rad Laboratories Inc is 7.33, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 365.00, with a high of 375.00 and a low of 325.00.

Score

Industry at a Glance

Previous score

7.33

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Bio Rad Laboratories Inc is 7.01, ranking 61 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 324.22 and the support level at 283.12, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.94

Change

0.07

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Bio Rad Laboratories Inc is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 101.60%, representing a quarter-over-quarter decrease of 1.53%. The largest institutional shareholder is First Eagle Investment, holding a total of 2.52M shares, representing 11.50% of shares outstanding, with 68.52% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

First Eagle Investment Management, L.L.C.

Star Investors

2.52M

+0.12%

Alice N. Schwartz Revocable Trust

1.78M

--

The Vanguard Group, Inc.

Star Investors

1.79M

-2.88%

BlackRock Institutional Trust Company, N.A.

1.48M

-3.98%

Schwartz (Norman D)

1.39M

+214.86%

Dimensional Fund Advisors, L.P.

1.06M

+6.34%

Veritas Asset Management LLP

844.04K

-2.21%

Ariel Investments, LLC

Star Investors

809.48K

-1.12%

EARNEST Partners, LLC

609.28K

+0.56%

State Street Investment Management (US)

571.60K

-2.18%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Bio Rad Laboratories Inc is 7.66, ranking 34 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.17. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Bio Rad Laboratories Inc

BIO

7.84 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.61 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Cencora Inc

COR

8.47 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Becton Dickinson and Co

BDX

8.46 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

AxoGen Inc

AXGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Align Technology Inc

ALGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment